Click aici pentru detalii

ambulatory electrocardiograms. Am J Cardiol 1984; 53: 1577-82.
[73] Zehender M, Buchner C, Meinertz T, Just H. Prevalence,
circumstances, mechanisms, and risk stratification of sudden cardiac
death in unipolar single-chamber ventricular pacing. Circulation 1992;
85: 596-605.
[74] E.ect of metoprolol CR/XL in chronic heart failure:
Metoprolol CR/XL Randomised Intervention Trial in Congestive
Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7.
[75] Rankin AS, Cobbe SM. Arrhythmias and sudden death in
heart failure: can we prevent them? In: McMurray JJV, Cleland, eds.
Heart failure in clinical practice. London: Martin Dunitz Ltd, 1996;
189-205.
[76] Uretsky BF, Thygesen K, Armstrong PW et al. Acute coronary
findings at autopsy in heart failure patients with sudden death: results
from the assessment of treatment with lisinopril and survival (ATLAS)
trial. Circulation 2000; 102: 611-6.
[77] Kjekshus J. Arrhythmias and mortality in congestive heart
failure. Am J Cardiol 1990; 65: 42I-48I.
[78] Yap Y, Duong T, Bland M et al. Left ventricular ejection
fraction in the trombolytic era remains a powerful predictor of longterm
but not short-term all-cause, cardiac and arrhythmic mortality
after myocardial infarction - a secondary meta-analysis of 2828
patients. Heart 2000; 83: 55.
[79] Stevenson WG, Ridker PM. Should survivors of myocardial
infarction with low ejection fraction be routinely referred to
arrhythmia specialists? JAMA 1996; 276: 481-5.
[80] Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik
M. Predictive power of increased heart rate versus depressed left
ventricular ejection fraction and heart rate variability for risk
stratification after myocardial infarction. Results of a two-year followup
study. J Am Coll Cardiol 1996; 27: 270-6.
[81] La Rovere MT, Bigger JT, Jr, Marcus FI, Mortara A,Schwartz
PJ. Baroreflex sensitivity and heart-rate variability in prediction of total
cardiac mortality after myocardialinfarction. ATRAMI (Autonomic
Tone and ReflexesAfter Myocardial Infarction) Investigators. Lancet
1998; 351: 478-84.
[82] White HD, Norris RM, Brown MA, Brandt PW, Whitlock
RM, Wild CJ. Left ventricular end-systolic volume as the major
determinant of survival after recovery from myocardial infarction.
Circulation 1987; 76: 44-51.
[83] Nicolosi GL, Latini R, Marino P et al. The prognostic valueof
predischarge quantitative two-dimensional echocardiographic
measurements and the effects of early lisinopril treatment on left
ventricular structure and function after acute myocardial infarction in
the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza
nell’Infarto Miocardico. Eur Heart J 1996; 17: 1646-56.
[84] Maggioni AP, Zuanetti G, Franzosi MG et al. Prevalence and
prognostic significance of ventricular arrhythmias after acute
myocardial infarction in the fibrinolytic era. GISSI-2 results.
Circulation 1993; 87: 312-22.
[85] Farrell TG, Bashir Y, Cripps T et al. Risk stratification for
arrhythmic events in postinfarction patients based on heart rate
variability, ambulatory electrocardiographic variables and the signalaveraged
electrocardiogram. J Am Coll Cardiol 1991; 18: 687-97.
[86] McClements BM, Adgey AA. Value of signal-averaged
electrocardiography, radionuclide ventriculography, Holter monitoring
and clinical variables for prediction of arrhythmic events in survivors
of acute myocardial infarction in the thrombolytic era. J Am Coll
Cardiol 1993; 21: 1419-27.
[87] Richards DA, Byth K, Ross DL, Uther JB. What is the best
predictor of spontaneous ventricular tachycardia and sudden death
after myocardial infarction? Circulation 1991; 83: 756-63.
[88] Mushlin AI, Hall WJ, Zwanziger J et al. The coste ectiveness
of automatic implantable cardiac defibrillators: results from MADIT.
Multicenter Automatic Defibrillator Implantation Trial. Circulation
1998; 97: 2129-35.
62
[89] Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky
EN, Hafley G. A randomized study of the prevention of sudden death
in patients with coronary artery disease. Multicenter Unsustained
Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-90.
[90] Andresen D, Steinbeck G, Bruggemann T. Can the MADIT
results be applied to myocardial infarction patients at hospital
discharge? Abstr J Am Coll Cardiol 1998; 31(Suppl A): 308.
[91] Steinberg JS, Regan A, Sciacca RR, Bigger JT, Jr, Fleiss JL.
Predicting arrhythmic events after acute myocardial infarction using
the signal-averaged electrocardiogram. Am J Cardiol 1992; 69: 13-21.
[92] Steinberg JS, Hochman JS, Morgan CD et al. Effects of
thrombolytic therapy administered 6 to 24 hours after myocardial
infarction on the signal-averaged ECG. Results of a multicenter
randomized trial. LATE Ancillary Study Investigators. Late Assessment
of Thrombolytic Efficacy. Circulation 1994; 90: 746-52.
[93] Malik M, Kulakowski P, Odemuyiwa O et al. Effect of
thrombolytic therapy on the predictive value of signalaveraged
electrocardiography after acute myocardial infarction. Am J Cardiol
1992; 70: 21-5.
[94] Hermosillo AG, Araya V, Casanova JM. Risk stratification for
malignant arrhythmic events in patients with an acute myocardial
infarction: role of an open infarct-related artery and the signalaveraged
ECG. Coron Artery Dis 1995; 6: 973-83.
[95] Cain ME, Anderon JL, Arnsdorf MF, Mason JW, Scheinman
MM, Waldo AL. ACC Consensus Document on Signal-Averaged
Electrocardiography. J Am Coll Cardiol 1996; 27: 238-49.
[96] Zuanetti G, Neilson JM, Latini R, Santoro E, Maggioni AP,
Ewing DJ. Prognostic significance of heart rate variability in postmyocardial
infarction patients in the fibrinolytic era. The GISSI-2
results. Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarto
Miocardico. Circulation 1996; 94: 432-36.
[97] Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA,
Schwartz PJ. Depressed heart rate variability identifies postinfarction
patients who might benefit from prophylactic treatment with
amiodarone: a substudy of EMIAT (The European Myocardial Infarct
Amiodarone Trial). J Am Coll Cardiol 2000; 35: 1263-75.
[98] Schmidt G, Malik M, Barthel P et al. Heart-rate turbulence
after ventricular premature beats as a predictor of mortality after acute
myocardial infarction. Lancet 1999; 353: 1390-6.
[99] Schwartz PJ, Wolf S. QT interval prolongation as predictor
of sudden death in patients with myocardial infarction. Circulation
1978; 57: 1074-7.
[100] Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc
prolongation measured by standard 12-lead electrocardiography is an
independent risk factor for sudden death due to cardiac arrest.
Circulation 1991; 83: 1888-94.
[101] Zabel M, Klingenheben T, Franz MR, Hohnloser SH.
Assessment of QT dispersion for prediction of mortality or arrhythmic
events after myocardial infarction: results of a prospective, long-term
follow-up study. Circulation 1998; 97: 2543-50.
[102] Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans
J, Cohen RJ. T wave alternans as a predictor of recurrent ventricular
tachyarrhythmias in ICD recipients: prospective comparison with
conventional risk markers. J Cardiovasc Electrophysiol 1998; 9: 1258-68.
[103] Ikeda T, Sakata T, Takami M et al. Combined assessment of
T-wave alternans and late potentials used to predict arrhythmic events
after myocardial infarction. A prospective study. J Am Coll Cardiol
2000; 35: 722-30.
[104] Peterson ED, Shaw LJ, Cali. RM. Risk stratification after
myocardial infarction. Ann Intern Med 1997; 126: 561-82.
[105] Wellens HJ, Doevendans P, Smeets J et al. Arrhythmia risk:
electrophysiological studies and monophasic action potentials. Pacing
Clin Electrophysiol 1997; 20: 2560-5.
[106] Caruso AC, Marcus FI, Hahn EA, Hartz VL, Mason JW.
Predictors of arrhythmic death and cardiac arrest in the ESVEM trial.
Electrophysiologic Study Versus Electromagnetic Monitoring.
REVISTA ROMÅN~ DE CARDIOLOGIE Vol. XIX, Nr. 1, An 2004